Presentations:
Saturday, June 11 at 2:00PM PDT
Dosimetry in Multi-Center Trials- Case Studies
Session: CAT 7 | Image Quantification and Dosimetry in Radiopharmaceutical Therapy
Presenter: Jacob Hesterman, Ph.D. | Distinguished Scientist, Invicro
-------------------------------------------------
Monday, June 13 at 1:20PM - 1:30PM PDT
Phase 2 drug target engagement study of PLN-74809 in patients with idiopathic pulmonary fibrosis using a novel αvβ6 cystine knot PET imaging tracer
Session: All you want to learn about modern concepts in nuclear medicine
Presenter: Mirwais Wardak, Ph.D. | Instructor at Stanford University School of Medicine
Invicro co-authors:
Roger Gunn, Ph.D. | Chief Science Officer, Neuroscience
Gaia Rizzo, Ph.D. | Senior PET Scientist
Your Full-Service Imaging CRO
Invicro uniquely combines operational, scientific and medical expertise to support your drug discovery and development pipelines.
*Click titles below to learn more.*
Complete solutions for streamlined development, evaluation and clinical translation of radiopharmaceuticals
Molecular imaging solutions spanning from preclinical through late-phase clinical to support drug discovery and development
Custom biomarker assay validation, development and AI-powered image analysis services to gain spatial tissue insights
Advanced scientific, medical and operational expertise to deliver global studies from Phase I-IV
Primary method development for transfer from sponsor to label candidates, including biologics, small molecules, cells and more
Qualitative and quantitative image analytics for radiology and pathology studies, utilizing machine learning and artificial intelligence
XXXXXXXXXXXXXX
© 2022 Invicro. LLC. All Rights Reserved. info@invicro.com | www.invicro.com